Point72 Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-214,872
| Closed | -$9.67M | – | 1668 |
|
|
2024
Q3 | $9.67M | Sell |
214,872
-694,862
| -76% | -$31.3M | 0.02% | 510 |
|
|
2024
Q2 | $31.5M | Sell |
909,734
-290,168
| -24% | -$10.1M | 0.08% | 281 |
|
|
2024
Q1 | $34.7M | Sell |
1,199,902
-1,413,551
| -54% | -$40.9M | 0.08% | 269 |
|
|
2023
Q4 | $59.9M | Buy |
2,613,453
+1,505,313
| +136% | +$34.5M | 0.14% | 174 |
|
|
2023
Q3 | $18.5M | Buy |
+1,108,140
| New | +$18.5M | 0.05% | 388 |
|
|
2023
Q1 | – | Sell |
-316,500
| Closed | -$3.45M | – | 1932 |
|
|
2022
Q4 | $3.45M | Sell |
316,500
-2,221,493
| -88% | -$24.2M | 0.01% | 696 |
|
|
2022
Q3 | $21.4M | Sell |
2,537,993
-1,518,207
| -37% | -$12.8M | 0.09% | 292 |
|
|
2022
Q2 | $32.1M | Buy |
4,056,200
+1,141,100
| +39% | +$9.03M | 0.14% | 199 |
|
|
2022
Q1 | $69M | Buy |
2,915,100
+495,337
| +20% | +$11.7M | 0.27% | 84 |
|
|
2021
Q4 | $82.8M | Sell |
2,419,763
-1,967,537
| -45% | -$67.3M | 0.33% | 58 |
|
|
2021
Q3 | $77.7M | Buy |
4,387,300
+3,232,100
| +280% | +$57.3M | 0.34% | 50 |
|
|
2021
Q2 | $51.8M | Buy |
1,155,200
+212,900
| +23% | +$9.55M | 0.23% | 98 |
|
|
2021
Q1 | $24.4M | Buy |
942,300
+392,300
| +71% | +$10.2M | 0.11% | 218 |
|
|
2020
Q4 | $11.1M | Buy |
+550,000
| New | +$11.1M | 0.05% | 398 |
|
|
2019
Q4 | – | Sell |
-162,500
| Closed | -$1.95M | – | 1141 |
|
|
2019
Q3 | $1.95M | Buy |
+162,500
| New | +$1.95M | 0.01% | 544 |
|
|
2018
Q1 | – | Sell |
-120,000
| Closed | -$2.5M | – | 905 |
|
|
2017
Q4 | $2.5M | Buy |
+120,000
| New | +$2.5M | 0.01% | 578 |
|